Search peptides, terms, sources/

Sources (161)

Every study, trial and regulator document PeptGuru cites. Each has its own page with its limitations and the findings that rely on it.

161 sources

Every source cited on PeptGuru, newest first
SourceKindDesignYearCited in
Abaloparatide and pelvic fracture healing: a phase 2 randomized placebo-controlled trialNieves et al., 2026ResearchHuman clinical trial, RCT2026Abaloparatide
Body composition, hepatic fat, metabolic, and safety outcomes of Tesamorelin, a GHRH analogue, in…Badran et al., 2026ResearchMeta-analysis, RCT2026Tesamorelin
Cardiovascular outcomes with survodutide in adults with obesity at increased cardiovascular risk…Bozkurt et al., 2026ResearchHuman clinical trial, RCT2026Survodutide
ClinicalTrials.gov registry search for KPV (Lys-Pro-Val) as an intervention, checked 14 November 2026ClinicalTrials.gov, 2026Regulatory / officialClinical trial registry entry2026KPV
Counterfeit weight loss pens worth £2 million seized by MHRA and West Midlands PoliceMHRA, 2026Regulatory / official—2026Retatrutide
Differentiating hypothalamic from pituitary adrenal insufficiency: underlying causes and diagnostic utility of…Okada et al., 2026ResearchHuman observational2026GHRP-2
Efficacy and safety of mazdutide in adults with obesity or overweight: a US-based, multicentre, phase 2…Hsia et al., 2026ResearchHuman clinical trial, RCT2026Mazdutide
Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease…The Lancet, 2026ResearchHuman clinical trial, RCT2026Semaglutide
Elamipretide: First ApprovalShirley, 2026ResearchNarrative review2026Elamipretide
Forsteo solution for injection in pre-filled pen (teriparatide): Summary of Product CharacteristicseMC, 2026Regulatory / official—2026Teriparatide
GLP-1 medicines for weight loss and diabetes: what you need to knowMHRA, 2026Regulatory / officialGovernment guidance2026Liraglutide, Semaglutide, Tirzepatide
Growth Hormone-Releasing Peptide-6 (GHRP-6) Ameliorates Post-Infarct Ventricular Remodeling and Systolic…Wang et al., 2026ResearchAnimal-preclinical2026GHRP-6
Guidance Note 8: A guide to what is a medicinal productMHRA, 2026Regulatory / officialRegulatory / legislative document2026GHK-Cu
Hormones and skin pigmentation: fundamentals and clinical relevance (English title as indexed by Europe PMC)Bohm, 2026ResearchNarrative review2026Afamelanotide
Imcivree solution for injection (setmelanotide): Summary of Product CharacteristicsRhythm Pharmaceutical UK Ltd (company listed on eMC), 2026Regulatory / official—2026Setmelanotide
Investigational Peptides in Orthopaedic Practice: Evidence, Safety, and Patient Counseling for BPC-157…Tham et al., 2026ResearchNarrative review2026Thymosin beta-4
Mazdutide versus placebo in Chinese adults with type 2 diabetesZhu et al., 2026ResearchHuman clinical trial, RCT2026Mazdutide
MHRA Products database: active substance index (A to Z), checked 14 November 2026Medicines and Healthcare products Regulatory Agency (MHRA), 2026Regulatory / official—2026Afamelanotide, AOD-9604, BPC-157, CJC-1295, Elamipretide, Epithalon, GHRP-2, GHRP-6, Hexarelin, Ipamorelin, Kisspeptin, KPV, Mazdutide, MOTS-c, Selank, Semax, Survodutide, TB-500, Thymosin beta-4
MHRA Products database: search for bremelanotide and VyleesiMedicines and Healthcare products Regulatory Agency (MHRA), 2026Regulatory / official—2026PT-141 (Bremelanotide)
Oxytocin concentrate for solution for infusion: Summary of Product Characteristics, eMCeMC, 2026Regulatory / official—2026Oxytocin
Semaglutide injection (weight-management product): Summary of Product Characteristics, eMCeMC, 2026Regulatory / official—2026Semaglutide
Setmelanotide for the Treatment of Acquired Hypothalamic ObesityMiller et al., 2026ResearchHuman clinical trial, RCT2026Setmelanotide
Setmelanotide in Bardet-Biedl Syndrome: A 52-Week Comparison of Phase 3 Trial Participants With a Matched…Argente et al., 2026ResearchHuman clinical trial, Human observational2026Setmelanotide
Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease…Kaplan et al., 2026ResearchHuman clinical trial, RCT2026Survodutide
Survodutide Once Weekly for the Treatment of Adults with Obesityle Roux et al., 2026ResearchHuman clinical trial, RCT2026Survodutide
Survodutide Once Weekly in Adults with Obesity and Type 2 DiabetesWharton et al., 2026ResearchHuman clinical trial, RCT2026Survodutide
Systemic MOTS-c levels are increased in adults with obesity in association with metabolic dysregulation and…Yoon et al., 2026ResearchHuman observational2026MOTS-c
The emerging landscape of performance-enhancing peptides modulating the GH-IGF1 axisDominikowski et al., 2026Research—2026AOD-9604
Thymosin Beta-4 and TB-500 in Tissue Healing, Regeneration, and Musculoskeletal Repair, A Scoping ReviewMcGuire et al., 2026ResearchScoping review2026TB-500
Tirzepatide injection: Summary of Product Characteristics, eMCeMC, 2026Regulatory / official—2026Tirzepatide
Treatment With Mazdutide for Weight Reduction in Chinese Adults With Obesity: The GLORY-2 Randomized Clinical…Gao et al., 2026ResearchHuman clinical trial, RCT2026Mazdutide
Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3eBioMedicine, 2025ResearchAnimal-preclinical, In-vitro2025Cagrilintide
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity (REDEFINE 1)Garvey et al., 2025ResearchHuman clinical trial, RCT2025Cagrilintide
Effect of abaloparatide on fracture incidence and bone mineral density in postmenopausal women with…DeSapri et al., 2025ResearchHuman clinical trial, Human observational2025Abaloparatide
Efficacy of thymosin alpha 1 for sepsis: a systematic review and meta-analysis of randomized controlled trialsGu et al., 2025ResearchMeta-analysis, RCT, Systematic review2025Thymosin Alpha-1
Eladynos solution for injection in pre-filled pen (abaloparatide): Summary of Product CharacteristicsTheramex Ireland Limited (marketing authorisation holder), 2025Regulatory / official—2025Abaloparatide
Emerging Use of BPC-157 in Orthopaedic Sports Medicine, A Systematic ReviewVasireddi et al., 2025ResearchSystematic review2025BPC-157
FDA Grants Accelerated Approval to First Treatment for Barth SyndromeFDA, 2025Regulatory / official—2025Elamipretide
Mazdutide: First ApprovalShirley, 2025ResearchNarrative review2025Mazdutide
Multifunctionality and Possible Medical Application of the BPC 157 Peptide, Literature and Patent ReviewJozwiak et al., 2025ResearchNarrative review2025BPC-157
Once-Weekly Mazdutide in Chinese Adults with Obesity or OverweightJi et al., 2025ResearchHuman clinical trial, RCT2025Mazdutide
Overview of Epitalon - Highly Bioactive Pineal Tetrapeptide with Promising PropertiesAraj et al., 2025Research—2025Epithalon
PMDA medicinal product information: GHRP Kaken 100 Injection (pralmorelin hydrochloride), package insertPharmaceuticals and Medical Devices Agency (PMDA) et al., 2025Regulatory / official—2025GHRP-2
Probability of achieving bone mineral density treatment targets with abaloparatide and teriparatideCosman et al., 2025ResearchHuman observational2025Abaloparatide
The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo…Wu et al., 2025ResearchHuman clinical trial, RCT2025Thymosin Alpha-1
Thymosin alpha 1 alleviates inflammation and prevents infection in patients with severe acute pancreatitis…Tian et al., 2025ResearchMeta-analysis, RCT, Systematic review2025Thymosin Alpha-1
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5)Aronne et al., 2025ResearchHuman clinical trial, RCT2025Tirzepatide
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity (SUMMIT)Packer et al., 2025ResearchHuman clinical trial, RCT2025Tirzepatide
Tirzepatide on obstructive sleep apnea-related cardiometabolic risk: secondary outcomes of the SURMOUNT-OSA…Nature Medicine, 2025ResearchHuman clinical trial, RCT2025Tirzepatide
FDA Briefing Document, Pharmacy Compounding Advisory Committee: CJC-1295-Related Bulk Drug SubstancesFDA, 2024Regulatory / officialRegulatory / legislative document2024CJC-1295
Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis…Karaa et al., 2024ResearchHuman clinical trial, RCT2024Elamipretide
Long-term efficacy and safety of elamipretide in patients with Barth syndrome: 168-week open-label extension…Thompson et al., 2024ResearchHuman clinical trial2024Elamipretide
Simultaneous quantification of TB-500 and its metabolites in in-vitro experiments and rats by UHPLC-Q-Exactive…Rahaman et al., 2024ResearchAnimal-preclinical2024Thymosin beta-4
The effects of cholecalciferol and afamelanotide on vitamin D levels in erythropoietic protoporphyria: a…Kluijver et al., 2024ResearchHuman observational2024Afamelanotide
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a…Sanyal et al., 2024ResearchHuman clinical trial, RCT2024Retatrutide
Effects of Kisspeptin on Sexual Brain Processing and Penile Tumescence in Men With Hypoactive Sexual Desire…Mills et al., 2023ResearchHuman clinical trial, RCT2023Kisspeptin
Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3…Karaa et al., 2023ResearchHuman clinical trial, RCT2023Elamipretide
Safety issues of tirzepatide (pancreatitis and gallbladder or biliary disease) in type 2 diabetes and obesity…Zeng et al., 2023ResearchHuman clinical trial, RCT2023Tirzepatide
Semaglutide and Cardiovascular Outcomes in Obesity without DiabetesLincoff et al., 2023ResearchHuman clinical trial, RCT2023Semaglutide
The effects of kisspeptin on food intake in women with overweight or obesityIzzi-Engbeaya et al., 2023ResearchHuman clinical trial, RCT2023Kisspeptin
Thymosin alpha1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical ApplicationTao et al., 2023ResearchNarrative review2023Thymosin Alpha-1
Triple-Hormone-Receptor Agonist Retatrutide for Obesity, A Phase 2 TrialJastreboff et al., 2023ResearchHuman clinical trial, RCT2023Retatrutide
0.1% RGN-259 (Thymosin ß4) Ophthalmic Solution Promotes Healing and Improves Comfort in Neurotrophic…Sosne et al., 2022ResearchRCT, Human clinical trial2022Thymosin beta-4
Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical…Thurston et al., 2022ResearchHuman clinical trial, RCT2022Kisspeptin
Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl…Haqq et al., 2022ResearchHuman clinical trial, RCT2022Setmelanotide
Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)Jastreboff et al., 2022ResearchHuman clinical trial, RCT2022Tirzepatide
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extensionWilding et al., 2022ResearchHuman clinical trial2022Semaglutide
A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of…Thompson et al., 2021ResearchHuman clinical trial, RCT2021Elamipretide
Afamelanotide (Scenesse): advice on prevention of phototoxicity in adult patients with erythropoietic…Scottish Medicines Consortium (SMC), 2021Regulatory / official—2021Afamelanotide
Clinical and dermoscopic changes of acquired melanocytic nevi of patients treated with afamelanotideArisi et al., 2021ResearchHuman observational2021Afamelanotide
Effect of aerobic and resistance exercise on the mitochondrial peptide MOTS-c in Hispanic and Non-Hispanic…Dieli-Conwright et al., 2021ResearchHuman observational, RCT2021MOTS-c
Freedom of Information response FOI 21/1237, Yellow Card reports for Melanotan II products (2011-2021) and…MHRA, 2021Regulatory / official—2021Melanotan II
Intra-Articular Injection of BPC 157 for Multiple Types of Knee PainLee et al., 2021ResearchHuman observational2021BPC-157, TB-500
Intranasal Oxytocin in Children and Adolescents with Autism Spectrum DisorderSikich et al., 2021ResearchHuman clinical trial, RCT2021Oxytocin
MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle…Reynolds et al., 2021ResearchAnimal-preclinical, In-vitro2021MOTS-c
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre…Lau et al., 2021ResearchHuman clinical trial, RCT2021Cagrilintide
Once-Weekly Semaglutide in Adults with Overweight or ObesityWilding et al., 2021ResearchHuman clinical trial, RCT2021Semaglutide
Self-Cross-Linked Hydrogel of Cysteamine-Grafted γ-Polyglutamic Acid Stabilized Tripeptide KPV for Alleviating…Sun et al., 2021ResearchAnimal-preclinical2021KPV
Teriparatide Did Not Increase Adult Osteosarcoma Incidence in a 15-Year US Postmarketing Surveillance StudyGilsenan et al., 2021ResearchHuman observational2021Teriparatide
A registered replication study on oxytocin and trustNature Human Behaviour, 2020ResearchHuman clinical trial, RCT2020Oxytocin
Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body…Sinha et al., 2020ResearchNarrative review2020Sermorelin
Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC…Clement et al., 2020ResearchHuman clinical trial2020Setmelanotide
Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonistWillard et al., 2020ResearchIn-vitro2020Tirzepatide
Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder, Two Randomized Phase 3 TrialsKingsberg et al., 2019ResearchHuman clinical trial, RCT2019PT-141 (Bremelanotide)
VYLEESI (bremelanotide injection), Prescribing Information / FDA approval documentation (NDA 210557)FDA, 2019Regulatory / official—2019PT-141 (Bremelanotide)
ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal…Bone et al., 2018ResearchHuman clinical trial2018Abaloparatide
Controversial Role of Kisspeptins/KiSS-1R Signaling System in Tumor DevelopmentFratangelo et al., 2018ResearchAnimal-preclinical, In-vitro, Narrative review2018Kisspeptin
Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis…Kendler et al., 2018ResearchHuman clinical trial, RCT2018Teriparatide
Systematic review and meta-analysis of reported adverse events of long-term intranasal oxytocin treatment for…Cai et al., 2018ResearchHuman clinical trial2018Oxytocin
The efficacy of semax in the treatment of patients at different stages of ischemic strokeGusev et al., 2018ResearchHuman clinical trial2018Semax
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals…le Roux et al., 2017ResearchHuman clinical trial, RCT2017Liraglutide
A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation…Abbara et al., 2017ResearchHuman clinical trial, RCT2017Kisspeptin
Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A…Miller et al., 2016ResearchHuman clinical trial, RCT2016Abaloparatide
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes (LEADER)Marso et al., 2016ResearchHuman clinical trial, RCT2016Liraglutide
Selank Administration Affects the Expression of Some Genes Involved in GABAergic NeurotransmissionVolkova et al., 2016ResearchAnimal-preclinical2016Selank
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight ManagementPi-Sunyer et al., 2015ResearchHuman clinical trial, RCT2015Liraglutide
Afamelanotide for Erythropoietic ProtoporphyriaLangendonk et al., 2015ResearchHuman clinical trial, RCT2015Afamelanotide
Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation…Abbara et al., 2015ResearchHuman clinical trial, RCT2015Kisspeptin
GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin RegenerationPickart et al., 2015Research—2015GHK-Cu
Long-term observational study of afamelanotide in 115 patients with erythropoietic protoporphyriaBiolcati et al., 2015ResearchHuman observational2015Afamelanotide
The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin…Lee et al., 2015ResearchAnimal-preclinical, In-vitro2015MOTS-c
Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, Phase II clinical trial…Sosne et al., 2015ResearchRCT, Human clinical trial2015Thymosin beta-4
Thymosin β4 significantly improves signs and symptoms of severe dry eye in a phase 2 randomized trialSosne et al., 2015ResearchRCT, Human clinical trial2015Thymosin beta-4
Determination That GEREF (Sermorelin Acetate) Injection Products Were Not Withdrawn From Sale for Reasons of…Federal Register, 2013Regulatory / officialRegulatory / legislative document2013Sermorelin
Pharmacokinetic study of Growth Hormone-Releasing Peptide 6 (GHRP-6) in nine male healthy volunteersCabrales et al., 2013ResearchHuman clinical trial2013GHRP-6
Safety and Tolerability of the Hexadecapeptide AOD9604 in HumansStier et al., 2013ResearchHuman clinical trial, RCT2013AOD-9604
Single administration of tripeptide α-MSH(11-13) attenuates brain damage by reduced inflammation and apoptosis…Schaible et al., 2013ResearchAnimal-preclinical2013KPV
The arginine and GHRP-2 tests as alternatives to the insulin tolerance test for the diagnosis of adult GH…Kinoshita et al., 2013ResearchHuman clinical trial2013GHRP-2
Egrifta (tesamorelin), EPAR, Withdrawal of marketing-authorisation applicationEMA, 2012Regulatory / official—2012Tesamorelin
A review of safety, side-effects and subjective reactions to intranasal oxytocin in human researchMacDonald et al., 2011Research—2011Oxytocin
Melanotan-associated melanomaPaurobally et al., 2011ResearchCase report / case series2011Melanotan II
A randomized, placebo-controlled, single and multiple dose study of intravenous thymosin beta4 in healthy…Ruff et al., 2010ResearchRCT, Human clinical trial2010TB-500, Thymosin beta-4
The effect of thymosin treatment of venous ulcersGuarnera et al., 2010ResearchRCT, Human clinical trial2010Thymosin beta-4
A cosmetic anti-ageing product improves photoaged skin: a double-blind, randomized controlled trialWatson et al., 2009ResearchHuman clinical trial, RCT2009GHK-Cu
Factors other than sex steroids modulate GHRH and GHRP-2 efficacies in men: evaluation using a GnRH…Veldhuis et al., 2009ResearchHuman clinical trial2009GHRP-2
Ghrelin and GHRP-6-induced ACTH and cortisol release in thyrotoxicosisPituitary, 2009ResearchHuman clinical trial2009GHRP-6
Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: A…Yang et al., 2008ResearchMeta-analysis, RCT2008Thymosin Alpha-1
Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized…Zozulia et al., 2008ResearchHuman clinical trial2008Selank
Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel…Kannengiesser et al., 2008ResearchAnimal-preclinical2008KPV
PepT1-mediated tripeptide KPV uptake reduces intestinal inflammationDalmasso et al., 2008ResearchIn-vitro, Animal-preclinical2008KPV
Metabolic Effects of a Growth Hormone-Releasing Factor in Patients with HIVFalutz et al., 2007ResearchHuman clinical trial, RCT2007Tesamorelin
Teriparatide or alendronate in glucocorticoid-induced osteoporosisSaag et al., 2007ResearchHuman clinical trial, RCT2007Teriparatide
Geroprotective effect of epithalamine (pineal gland peptide preparation) in elderly subjects with accelerated…Korkushko et al., 2006Research—2006Epithalon
Prolonged Stimulation of Growth Hormone (GH) and Insulin-Like Growth Factor I Secretion by CJC-1295, a…Teichman et al., 2006ResearchHuman clinical trial, RCT2006CJC-1295
Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat…Dolotov et al., 2006ResearchAnimal-preclinical2006Semax
Oxytocin increases trust in humansKosfeld et al., 2005ResearchHuman clinical trial, RCT2005Oxytocin
Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain…Eremin et al., 2005ResearchAnimal-preclinical2005Semax
Blockade of the growth hormone (GH) receptor unmasks rapid GH-releasing peptide-6-mediated tissue-specific…Muller et al., 2001ResearchHuman clinical trial, RCT2001GHRP-6
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with…Neer et al., 2001ResearchHuman clinical trial, RCT2001Teriparatide
Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and…Arvat et al., 2001ResearchHuman clinical trial, RCT2001Hexarelin
The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment…Heffernan et al., 2001ResearchAnimal-preclinical2001AOD-9604
The lipolytic action of human growth hormone fragment 177-191 in isolated rat adipocytesHeffernan et al., 2001ResearchAnimal-preclinical, In-vitro2001AOD-9604
GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adultsPopovic et al., 2000ResearchHuman clinical trial2000GHRP-6
Synergy of L-arginine and GHRP-2 stimulation of growth hormone in men and women: modulation by exerciseWideman et al., 2000ResearchHuman clinical trial2000GHRP-2
Cardiac effects of hexarelin in hypopituitary adultsBisi et al., 1999ResearchHuman clinical trial1999Hexarelin
Ghrelin is a growth-hormone-releasing acylated peptide from stomachKojima et al., 1999ResearchAnimal-preclinical, In-vitro1999GHRP-6
Pharmacokinetic-Pharmacodynamic Modeling of Ipamorelin, a Growth Hormone Releasing Peptide, in Human…Gobburu et al., 1999ResearchHuman clinical trial1999Ipamorelin
Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone…Prakash et al., 1999ResearchNarrative review1999Sermorelin
Tyr-Ala-hexarelin, a synthetic octapeptide, possesses the same endocrine activities of hexarelin and GHRP-2 in…Arvat et al., 1999ResearchHuman clinical trial, RCT1999GHRP-2, Hexarelin
Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH…Pandya et al., 1998ResearchHuman clinical trial, RCT1998GHRP-6
Growth hormone status during long-term hexarelin therapyRahim et al., 1998ResearchHuman clinical trial1998Hexarelin
Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly menVittone et al., 1997ResearchHuman clinical trial1997Sermorelin
Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing…Khorram et al., 1997ResearchHuman clinical trial, RCT1997Sermorelin
Desensitization from long-term intranasal treatment with hexarelin does not interfere with the biological…Klinger et al., 1996ResearchHuman clinical trial1996Hexarelin
Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical studyDorr et al., 1996ResearchHuman clinical trial1996Melanotan II
Hexarelin-induced growth hormone, cortisol, and prolactin release: a dose-response studyMassoud et al., 1996ResearchHuman clinical trial, RCT1996Hexarelin
A Research Study Looking at How a Single Dose of the Medicine Cagrilintide Works in Participants With Reduced…ClinicalTrials.govRegulatory / official——Cagrilintide
A Review on Semaglutide: An Oral Glucagon-Like Peptide 1 Receptor Agonist in Management of Type 2 Diabetes…PMCResearch——Semaglutide
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of PCO-02 (BPC-157) in Healthy VolunteersClinicalTrials.govRegulatory / officialClinical trial registry entry—BPC-157
BNF-derived guidance on managing risks of oxytocin infusion (water intoxication/hyponatraemia)NHS Specialist Pharmacy ServiceRegulatory / official——Oxytocin
Certain Bulk Drug Substances for Use in Compounding That May Present Significant Safety RisksFDARegulatory / official——BPC-157
Combination of 5-aminolevulinic acid and GHK peptide for androgenetic alopeciaLee et al.ResearchHuman clinical trial—GHK-Cu
Guidance on unlicensed medicinal products ("specials"), Guidance Note 14MHRARegulatory / officialRegulatory / legislative document—Sermorelin, Thymosin Alpha-1
Liraglutide (weight-management product): Summary of Product Characteristics, eMCeMCRegulatory / official——Liraglutide
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC), 8-11 April 2024EMARegulatory / official——Semaglutide
Melanocortin 4 receptor agonism enhances sexual brain processing in women with hypoactive sexual desire…Journal of Clinical InvestigationResearchHuman clinical trial, RCT—PT-141 (Bremelanotide)
MHRA reminds healthcare professionals to advise patients of the side effects of GLP-1 agonists and to report…MHRARegulatory / official——Semaglutide
Oxytocin (Syntocinon), Obstetrics, clinical guidanceNHS (Right Decisions Service et al.Regulatory / official——Oxytocin
Safety and Efficacy of Ipamorelin for Management of Post-Operative IleusClinicalTrials.govRegulatory / officialClinical trial registry entry—Ipamorelin
Semaglutide (Wegovy) approved to treat form of liver diseaseMHRARegulatory / official——Semaglutide
Topical GHK-Cu Gel for Acute Skin Wound Healing (trial registry entry)registered sponsor/investigatorRegulatory / officialRegulatory-clinical source—GHK-Cu

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.